Skip to content

Clinical trials

Hodgkin Disease trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hodgkin Disease Country / region: China Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20142
20161
20176
20183
20193
20204
20211
20224
20233
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status18
Completed7
Recruiting7
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese PLA General Hospital6
Peking University2
Akeso1
AstraZeneca1
Beijing Children's Hospital1
CStone Pharmaceuticals1
Children's Cancer Group, China1
FBD Biologics Limited1
Fudan University1
Genor Biopharma Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hodgkin Disease35
Lymphoma, Large-Cell, Anaplastic6
Recurrence6
Lymphoma5
Lymphoma, Non-Hodgkin5
Immunoblastic Lymphadenopathy2
Lymphoma, Extranodal NK-T-Cell2
Lymphoma, Large B-Cell, Diffuse2
Lymphoma, T-Cell2
Lymphoma, T-Cell, Peripheral2

Trials

Showing 51 to 35 of 35. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.